| Tretinoin | Approved Investigational Nutraceutical | SLC7A2 | 6542 |
downregulated | Tretinoin results in decreased expression of SLC7A2 mRNA | 8p22 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC7A2 | 6542 |
upregulated | Tretinoin results in increased expression of SLC7A2 mRNA | 8p22 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC7A5 | 8140 |
downregulated | Tretinoin results in decreased expression of SLC7A5 mRNA | 16q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC7A5 | 8140 |
upregulated | Tretinoin results in increased expression of SLC7A5 mRNA | 16q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC8A3 | 6547 |
upregulated | Tretinoin results in increased expression of SLC8A3 mRNA | 14q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLC9A3R1 | 9368 |
upregulated | Tretinoin results in increased expression of SLC9A3R1 mRNA | 17q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLCO2A1 | 6578 |
upregulated | Tretinoin results in increased expression of SLCO2A1 mRNA | 3q22.1-q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLCO4A1 | 28231 |
downregulated | Tretinoin results in decreased expression of SLCO4A1 mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SLCO4C1 | 353189 |
upregulated | Tretinoin results in increased expression of SLCO4C1 mRNA | 5q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLFN12 | 55106 |
upregulated | Tretinoin results in increased expression of SLFN12 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | SLIRP | 81892 |
downregulated | Tretinoin results in decreased expression of SLIRP mRNA | 14q24.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SLIT1 | 6585 |
downregulated | Tretinoin results in decreased expression of SLIT1 mRNA | 10q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLIT1 | 6585 |
upregulated | Tretinoin results in increased expression of SLIT1 mRNA | 10q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLIT2 | 9353 |
upregulated | Tretinoin results in increased expression of SLIT2 mRNA | 4p15.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SLITRK1 | 114798 |
downregulated | Tretinoin results in decreased expression of SLITRK1 mRNA | 13q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLITRK5 | 26050 |
downregulated | Tretinoin results in decreased expression of SLITRK5 mRNA | 13q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SLITRK6 | 84189 |
downregulated | Tretinoin results in decreased expression of SLITRK6 mRNA | 13q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SLITRK6 | 84189 |
upregulated | Tretinoin results in increased expression of SLITRK6 mRNA | 13q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD2 | 4087 |
downregulated | Tretinoin results in decreased expression of SMAD2 mRNA | 18q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD3 | 4088 |
upregulated | Tretinoin results in increased expression of SMAD3 mRNA | 15q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD4 | 4089 |
downregulated | Tretinoin results in decreased expression of SMAD4 mRNA | 18q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD6 | 4091 |
upregulated | Tretinoin results in increased expression of SMAD6 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD7 | 4092 |
upregulated | Tretinoin results in increased expression of SMAD7 mRNA | 18q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAD9 | 4093 |
upregulated | Tretinoin results in increased expression of SMAD9 mRNA | 13q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SMAGP | 57228 |
upregulated | Tretinoin results in increased expression of SMAGP mRNA | 12q13.13 | |